FDA updates list of inquiries from prospective generic drug applicants about RLD access — Read on s2027422842.t.en25.com/e/es
Nintedanib (Ofev, Boehringer Ingelheim) is now the first therapy approved for patients with interstitial lung disease associated with systemic sclerosis.…
A list of all drug products about which FDA has received inquiries related to RLD access, along with details including…